
Loading, please wait...

Loading, please wait...

Recent clinical observations emphasize the critical nature of perinatal dengue transmission, especially during large-scale outbreaks. This phenomenon occurs when the dengue virus (DENV) passes from a pregnant woman to her fetus or newborn. Consequently, this transmission can lead to various complications, ranging from mild fever to severe neonatal distress. A recent study in Argentina detailed six cases of vertical transmission involving DENV-2, offering valuable insights for clinicians worldwide.
During the study, most pregnant women developed symptoms shortly before or after giving birth. Specifically, fever and headache affected 66.7% of the mothers. Thrombocytopenia was also a common finding, matching the frequency of other symptoms. Notably, some women experienced more severe complications, such as gynecorrhagia and pleural effusion. The median interval from the onset of maternal symptoms to delivery was four days. Therefore, healthcare providers must monitor symptomatic pregnant women closely during the peripartum period.
All newborns in this series were full-term and had appropriate birth weights. However, five out of six neonates became symptomatic. Fever was the most frequent manifestation, occurring in 83.3% of the infants. Additionally, many neonates experienced respiratory distress. Laboratory tests revealed thrombocytopenia in half of the cases. One severe case even involved plasma leakage, a hallmark of severe dengue. Despite these challenges, all newborns recovered well after receiving supportive care for approximately nine days.
Effective management of perinatal dengue transmission requires early diagnostic suspicion. Clinicians should include dengue in the differential diagnosis for any neonate presenting with fever or sepsis-like symptoms in endemic regions. Early testing for NS1 antigen and IgM antibodies is essential for both the mother and the infant. Furthermore, supportive care remains the primary treatment strategy. This includes careful fluid management and monitoring of platelet counts to prevent further complications.
Vertical transmission of DENV-2 can cause significant neonatal illness even in full-term infants. Therefore, medical professionals must stay vigilant during outbreaks. Early recognition and adequate clinical management are vital for ensuring favorable outcomes for both mothers and their babies.
Common symptoms include fever, respiratory distress, and thrombocytopenia. In some severe cases, neonates may also experience plasma leakage or bleeding tendencies.
Transmission usually occurs when the mother develops symptoms near the time of delivery. In this series, the median time from maternal symptom onset to birth was four days.
Management is primarily supportive. Doctors focus on symptomatic relief, fluid balance, and close monitoring of laboratory parameters like platelet counts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider for any medical concerns. Refer to the latest local and national guidelines for clinical practice.
References
Quipildor MO et al. Perinatal Transmission of Dengue Virus Type 2 in Northern Argentina: A Series of 6 Cases. Pediatr Infect Dis J. 2026 Mar 10. doi: 10.1097/INF.0000000000005212. PMID: 41805264.
National Center for Vector Borne Diseases Control (NCVBDC). National Guidelines for Clinical Management of Dengue Fever. Ministry of Health & Family Welfare, Government of India; 2023.
World Health Organization. National Guideline for Clinical Management of Dengue. WHO; 2022.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A clinical analysis of vertical Dengue Type 2 transmission cases, detailing maternal symptoms, neonatal clinical manifestations, and supportive care outcome...
8 months ago

A multicenter study validates a machine learning-guided recalibrated SOFA score, demonstrating significantly improved ICU mortality discrimination while preserving the simple, additive, point-based structure critical for bedside decision-making.
Today

A landmark study reveals that lipid-rich malignant ascites alters the T-cell metabolic transcriptome, causing cholesterol efflux and impaired fatty acid oxidation. This suppresses TCR signalling and blocks BiTE immunotherapy, while lipid depletion restores antitumour cytotoxicity in ovarian cancer.
Today

A registry study of 4,989 patients evaluates transvenous lead extraction for right-sided cardiac devices. Despite longer dwell times and older leads, right-sided extractions achieve high procedural success and comparable safety to left-sided approaches.
Today

Recent crash analyses demonstrate significant variations in traffic injury severity across vehicle seating positions. Electric vehicle passengers face disproportionately higher trauma risks than drivers, particularly during airbag deployments, demanding adapted emergency assessment and clinical vigilance.
Today

Understand the causal role of Lipoprotein(a) in cardiovascular disease, why international guidelines recommend once-in-a-lifetime molar testing, and the clinical implications of recent phase 3 RNA outcome trials.
Today